BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Neuron
,
Human chorionic gonadotropin
,
Rosiglitazone
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
beta Synuclein
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Mice overexpressing human alpha-synuclein at 3 and 9 months of age
Microglia treated with conditioned media from SH-SY5Y cells overexpressing α-Synuclein
Colon epithelial cells of Parkinson's disease model overexpressing SNCA treated with antibiotics
Neural progenitor cells derived from embryonic stem WA09 cells for 21 days
Explore Curated Studies Results
Literature
Most Relevant Literature
β-Synuclein: An Enigmatic Protein with Diverse Functionality.
High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeld…
Plasma β-synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical …
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
Relationship of serum beta-synuclein with blood biomarkers and brain atrophy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein
K0706 for Patients Diagnosed With Dementia With Lewy Bodies
Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy …
Nilotinib in Huntington's Disease
Efficacy of Cognitive Rehabilitation Using Virtual Reality and Computer-based Cognitive Stimulation …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ